CA Stock MarketDetailed Quotes

Medicenna Therapeutics Corp (MDNA)

Watchlist
  • 0.970
  • +0.050+5.43%
15min DelayMarket Closed Jan 22 16:00 ET
80.91MMarket Cap-5.71P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Medicenna Therapeutics Corp (MDNA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-1.03%5.47M
36.36%5.51M
9.27%20.41M
42.94%5.72M
7.18%5.12M
1.66%5.53M
-9.40%4.04M
14.54%18.67M
34.67%4M
-2.93%4.78M
Selling and administrative expenses
-24.96%1.34M
2.39%1.28M
-24.93%5.91M
-43.57%1.21M
-7.12%1.66M
-22.20%1.79M
-23.88%1.25M
12.51%7.87M
54.41%2.14M
-9.63%1.78M
-General and administrative expense
-24.96%1.34M
2.39%1.28M
-24.93%5.91M
-43.57%1.21M
-7.12%1.66M
-22.20%1.79M
-23.88%1.25M
12.51%7.87M
54.41%2.14M
-9.63%1.78M
Research and development costs
10.23%4.11M
51.22%4.21M
33.74%14.44M
141.22%4.49M
15.08%3.44M
18.89%3.73M
-1.07%2.78M
16.08%10.8M
17.47%1.86M
1.56%2.99M
Depreciation amortization depletion
90.00%19K
280.00%19K
1,000.00%55K
1,800.00%19K
950.00%21K
900.00%10K
400.00%5K
0.00%5K
0.00%1K
0.00%2K
-Depreciation and amortization
90.00%19K
280.00%19K
1,000.00%55K
1,800.00%19K
950.00%21K
900.00%10K
400.00%5K
0.00%5K
0.00%1K
0.00%2K
Operating profit
1.03%-5.47M
-36.36%-5.51M
-9.27%-20.41M
-42.94%-5.72M
-7.18%-5.12M
-1.66%-5.53M
9.40%-4.04M
-14.54%-18.67M
-34.67%-4M
2.93%-4.78M
Net non-operating interest income (expenses)
-58.20%158K
-38.18%204K
12.69%1.35M
15.79%264K
34.04%378K
10.53%378K
-4.62%330K
31.07%1.2M
-40.31%228K
-17.06%282K
Non-operating interest income
-58.20%158K
-38.18%204K
12.69%1.35M
15.79%264K
34.04%378K
10.53%378K
-4.62%330K
31.07%1.2M
-40.31%228K
-17.06%282K
Other net income (expenses)
-56.45%429K
416.44%377K
190.75%7.25M
165.56%6.64M
6.85%-449K
-28.21%985K
-94.16%73K
-249.60%-7.99M
-699.61%-10.13M
-114.01%-482K
Gain on sale of security
-56.45%429K
416.44%377K
190.75%7.25M
165.56%6.64M
6.85%-449K
-28.21%985K
-94.16%73K
-249.60%-7.99M
-699.61%-10.13M
-114.01%-482K
Income before tax
-17.27%-4.88M
-35.50%-4.93M
53.64%-11.81M
108.54%1.19M
-4.30%-5.19M
-11.85%-4.16M
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
Income tax
Earnings from equity interest net of tax
Net income
-17.27%-4.88M
-35.50%-4.93M
53.64%-11.81M
108.54%1.19M
-4.30%-5.19M
-11.85%-4.16M
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
Net income continuous operations
-17.27%-4.88M
-35.50%-4.93M
53.64%-11.81M
108.54%1.19M
-4.30%-5.19M
-11.85%-4.16M
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
Noncontrolling interests
Net income attributable to the company
-17.27%-4.88M
-35.50%-4.93M
53.64%-11.81M
108.54%1.19M
-4.30%-5.19M
-11.85%-4.16M
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-17.27%-4.88M
-35.50%-4.93M
53.64%-11.81M
108.54%1.19M
-4.30%-5.19M
-11.85%-4.16M
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
Diluted earnings per share
-20.00%-0.06
-20.00%-0.06
59.46%-0.15
110.00%0.02
0.00%-0.07
0.00%-0.05
-25.00%-0.05
-131.25%-0.37
-233.33%-0.2
-250.00%-0.07
Basic earnings per share
-20.00%-0.06
-20.00%-0.06
59.46%-0.15
110.00%0.02
0.00%-0.07
0.00%-0.05
-25.00%-0.05
-131.25%-0.37
-233.33%-0.2
-250.00%-0.07
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -1.03%5.47M36.36%5.51M9.27%20.41M42.94%5.72M7.18%5.12M1.66%5.53M-9.40%4.04M14.54%18.67M34.67%4M-2.93%4.78M
Selling and administrative expenses -24.96%1.34M2.39%1.28M-24.93%5.91M-43.57%1.21M-7.12%1.66M-22.20%1.79M-23.88%1.25M12.51%7.87M54.41%2.14M-9.63%1.78M
-General and administrative expense -24.96%1.34M2.39%1.28M-24.93%5.91M-43.57%1.21M-7.12%1.66M-22.20%1.79M-23.88%1.25M12.51%7.87M54.41%2.14M-9.63%1.78M
Research and development costs 10.23%4.11M51.22%4.21M33.74%14.44M141.22%4.49M15.08%3.44M18.89%3.73M-1.07%2.78M16.08%10.8M17.47%1.86M1.56%2.99M
Depreciation amortization depletion 90.00%19K280.00%19K1,000.00%55K1,800.00%19K950.00%21K900.00%10K400.00%5K0.00%5K0.00%1K0.00%2K
-Depreciation and amortization 90.00%19K280.00%19K1,000.00%55K1,800.00%19K950.00%21K900.00%10K400.00%5K0.00%5K0.00%1K0.00%2K
Operating profit 1.03%-5.47M-36.36%-5.51M-9.27%-20.41M-42.94%-5.72M-7.18%-5.12M-1.66%-5.53M9.40%-4.04M-14.54%-18.67M-34.67%-4M2.93%-4.78M
Net non-operating interest income (expenses) -58.20%158K-38.18%204K12.69%1.35M15.79%264K34.04%378K10.53%378K-4.62%330K31.07%1.2M-40.31%228K-17.06%282K
Non-operating interest income -58.20%158K-38.18%204K12.69%1.35M15.79%264K34.04%378K10.53%378K-4.62%330K31.07%1.2M-40.31%228K-17.06%282K
Other net income (expenses) -56.45%429K416.44%377K190.75%7.25M165.56%6.64M6.85%-449K-28.21%985K-94.16%73K-249.60%-7.99M-699.61%-10.13M-114.01%-482K
Gain on sale of security -56.45%429K416.44%377K190.75%7.25M165.56%6.64M6.85%-449K-28.21%985K-94.16%73K-249.60%-7.99M-699.61%-10.13M-114.01%-482K
Income before tax -17.27%-4.88M-35.50%-4.93M53.64%-11.81M108.54%1.19M-4.30%-5.19M-11.85%-4.16M-27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M
Income tax
Earnings from equity interest net of tax
Net income -17.27%-4.88M-35.50%-4.93M53.64%-11.81M108.54%1.19M-4.30%-5.19M-11.85%-4.16M-27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M
Net income continuous operations -17.27%-4.88M-35.50%-4.93M53.64%-11.81M108.54%1.19M-4.30%-5.19M-11.85%-4.16M-27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M
Noncontrolling interests
Net income attributable to the company -17.27%-4.88M-35.50%-4.93M53.64%-11.81M108.54%1.19M-4.30%-5.19M-11.85%-4.16M-27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -17.27%-4.88M-35.50%-4.93M53.64%-11.81M108.54%1.19M-4.30%-5.19M-11.85%-4.16M-27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M
Diluted earnings per share -20.00%-0.06-20.00%-0.0659.46%-0.15110.00%0.020.00%-0.070.00%-0.05-25.00%-0.05-131.25%-0.37-233.33%-0.2-250.00%-0.07
Basic earnings per share -20.00%-0.06-20.00%-0.0659.46%-0.15110.00%0.020.00%-0.070.00%-0.05-25.00%-0.05-131.25%-0.37-233.33%-0.2-250.00%-0.07
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.23%
Sample Name
Sample Code
 +4.93%
Sample Name
Sample Code
 +4.12%
4
KUAISHOU-W
01024
+3.70%
5
BABA-W
09988
+1.38%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
Tariff game between the US and Europe shakes the market! Will TACO happen again?
Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More
Options Weekly 0119 | Greenland tariff standoff, gold and silver surge again, shocking reversal in Fed chair nominee! Watch Intel, Netflix earnings reports
The real danger in the 2026 market isn't black swan events, but rather the changes you've become accustomed to ignoring.

- No more -